Track ResMed Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

ResMed Inc. RMD.VI · Stock Open ResMed Inc. in new tab

203.50 EUR
P/E
22.74
EPS
8.95
Yield
1.12%
P/B
5.19
ROE
24.27
Beta
0.75
Loading chart...
Key Metrics
P/E22.74
EPS8.95
Book Value39.17
Price to Book5.19
Debt/Equity12.54
% Insiders0.499%
Growth
Revenue Growth0.09%
Earnings Growth0.02%
Dividend
Dividend Yield1.12%
Annual dividends2.26 EUR
Ex-Div. DateAug. 20, 2026
Payout23.01%
5y avg Yield0.87%

DCF Valuation

Tweak assumptions to recompute fair value for ResMed Inc. (RMD.VI)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

ResMed Inc. Logo ResMed Inc. Analysis (RMD.VI)

United States Health Care Official Website Stock

Is ResMed Inc. a good investment? ResMed Inc. (RMD.VI) is currently trading at 203.50 EUR.

In terms of valuation, the stock trades at a P/E ratio of 22.74. This valuation is generally in line with the broader market.

For income investors, ResMed Inc. pays a dividend yield of 1.12%. With a payout ratio of 23%, the dividend appears sustainable.

Investor FAQ

Does ResMed Inc. pay a dividend?

Yes, it pays an annual dividend of 2.26 EUR (1.12% yield).

What asset class is ResMed Inc.?

ResMed Inc. is classified as a Stock. You can compare it against 13 other assets in the "Related Symbols" list on this page.

Company Profile

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Exchange Ticker
ASX (Australia) RMD.AX
PNK (United States) RSMDF
MEX (Mexico) RMD.MX
VIE (Austria) RMD.VI
FRA (Germany) RMD.F
BER (Germany) RME.BE
STU (Germany) RME.SG
DUS (Germany) RME.DU
FRA (Germany) RME.F
FRA (Germany) RMEA.F
MUN (Germany) RME.MU
STU (Germany) RMEA.SG
SAO (Brazil) R1MD34.SA
Trades
Dividend Yield
1.12%
5y avg 0.87%
Annual Dividends
2.26EUR
Next Ex. Div Date
Aug. 20, 2026
Payout Ratio
23.01%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2027
1.70 EUR
Aug. 12, 2027 (estimated) 0.6118
May 13, 2027 (estimated) 0.5428
Feb. 11, 2027 (estimated) 0.5428
2026
2.15 EUR
Nov. 12, 2026 (estimated) 0.5562
Aug. 20, 2026 0.5665
May 14, 2026 0.5150
Feb. 12, 2026 0.5150
2025
1.94 EUR
Nov. 13, 2025 0.5150
Aug. 14, 2025 0.5150
May 8, 2025 0.4550
Feb. 13, 2025 0.4550
2024
1.73 EUR
Nov. 7, 2024 0.4550
Aug. 15, 2024 0.4550
May 8, 2024 0.4120
Feb. 7, 2024 0.4120
2023
1.58 EUR
Nov. 8, 2023 0.4120
Aug. 16, 2023 0.4120
May 10, 2023 0.3777
Feb. 8, 2023 0.3777
2022
1.48 EUR
Nov. 9, 2022 0.3777
Aug. 17, 2022 0.3777
May 11, 2022 0.3605
Feb. 9, 2022 0.3605
2021
1.39 EUR
Nov. 9, 2021 0.3605
Aug. 18, 2021 0.3605
May 12, 2021 0.3348
Feb. 10, 2021 0.3348
2020
1.34 EUR
Nov. 10, 2020 0.3348
Aug. 19, 2020 0.3348
May 13, 2020 0.3348
Feb. 12, 2020 0.3348
2019
0.99 EUR
Nov. 6, 2019 0.3348
Aug. 14, 2019 0.3348
May 8, 2019 0.3176
Upcoming Dividends
Name Payment Date Status Amount
ResMed Inc. Aug 20, 2026 0.566544 EUR
ResMed Inc. May 14, 2026 0.51504 EUR
ResMed Inc. Feb 12, 2026 0.51504 EUR
ResMed Inc. Nov 13, 2025 0.51504 EUR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion